Medindia

FDA Approves VITROS(R) Anti-HCV Assay for Use On VITROS 5600(R) Integrated and VITROS 3600(R) Immunodiagnostic Systems

RARITAN, N.J., July 21 Ortho Clinical Diagnostics today announced the U.S. Food and Drug Administration (FDA) approval of the VITROS((R)) Anti-HCV assay for use on the VITROS 5600((R)) Integrated and ...
Nasdaq

VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.

QuidelOrtho’s infectious disease test portfolio spans the healthcare continuum from point-of-care settings to high-throughput laboratories and is critical in addressing the growing syphilis epidemic ...
News Medical

FDA approves Ortho Clinical Diagnostics' anti-HIV 1+2 test for use on VITROS 5600 & 3600 systems

Ortho Clinical Diagnostics today announced U.S. Food and Drug Administration (FDA) approval of a diagnostic assay for the detection of antibodies to human immunodeficiency virus (HIV) types 1+2 ...
Medindia

VITROS(R) 3600 Immunodiagnostic System for Laboratory Diagnostics Receives 510(k) Clearance from the FDA

- High-Volume System Combines Accuracy and Efficiency with Broad Menu of Routine and Infectious Disease Immunoassays - RARITAN, N.J., Dec. 23 /PRNewswire/ -- Ortho Clinical Diagnostics today announced ...
Pharmabiz

Ortho seeks US FDA marketing approval for VITROS HIV combo assay for use on Vitros 3600 immunodiagnostic system

Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, has submitted a premarket approval (PMA) application to the US Food and Drug Administration (FDA) for the Vitros ...
irblog.prnewswire.com

FDA Approves Expanded Use for Ortho Clinical Diagnostics VITROS® HIV Combo Test

RARITAN, N.J., Nov. 28, 2018 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its VITROS ® Immunodiagnostic Products HIV Combo Reagent Pack and ...
newswise

FDA Approves Two Ortho Clinical Diagnostics Specialty Hepatitis B Assays

Newswise — Raritan, NJ (September 14, 2017) – Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, has received approval from the U.S. Food and Drug Administration (FDA) for ...
irblog.prnewswire.com

Ortho Clinical Diagnostics Launches VITROS® 4600 Chemistry System for Mid- to High-Volume Laboratories

RARITAN, N.J., July 22, 2011 /PRNewswire/ -- Ortho Clinical Diagnostics (OCD) today announced the launch of the VITROS® 4600 Chemistry System, a state-of-the-art analyzer that delivers high-quality, ...
markets.financialcontent

VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.

QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”) has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its VITROS syphilis assay as part of its menu, strengthening ...
streetinsider

QuidelOrtho (QDEL): VITROS Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.

QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”) has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its VITROS syphilis assay as part of its menu, strengthening ...